Skip to content

Open Hemorrohoidectomy Vs Transanal Hemorrhoidal Desarterialization in Hemorrhoids Grade III: The Effect on Symptoms

Open Hemorrohoidectomy Versus Transanal Hemorrhoidal Desarterialization in Hemorrhoids Grade III: The Effect on Symptons: An Open-label Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06420986
Enrollment
50
Registered
2024-05-20
Start date
2021-08-12
Completion date
2024-04-17
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids Third Degree

Keywords

hemorrhoids third degree, botulinum Toxin, Hemorrhoidectomy, Transanal Hemorrhoidal Dearterialization, hemorrhoidal Disease Symptom Score

Brief summary

The goal of this clinical trial is to learn if open hemorroidectomy diminishes symptoms compared to transanal hemorrhoidal desarterialization (THD) in patients presenting with hemorrhoids grade III. The main question it aims to answer is: \- Do patients undergoing open hemorroidectomy present with lesser symptoms 1 year after surgery, compared to those undergoing a THD? Researchers will compare open hemorroidectomy to THD in terms of symptom response one year after the procedure. Participants will: * Undergo surgical treatment of hemorroids performed by one of the two techniques: open hemorroidectomy versus THD. * Fill in symptom forms before and one year after the surgical procedure. * Attend control visits one week, one month, three months and one year after the surgical procedure.

Interventions

Surgical treatment of Hemorrhoids. Removal of hemorrohids leaving the wounds open. Surgical technique described by Milligan Morgan

PROCEDURETransanal Hemorrhoidal Dearterialization

Surgical treatment of Hemorrhoids. This operation involves no excision. The hemorrhoidal arteries are ligated and the hemorrhoial prolapse is treated by a suture mucopexi. Described by Rato

Sponsors

Hospital Son Llatzer
Lead SponsorOTHER
Fundació d'investigació Sanitària de les Illes Balears
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age older than 18. * Hemorroids grade III. * Surgical indication for hemorroid treatment. * Signed informed consent.

Exclusion criteria

* Acute hemorroidal disease. * Previous hemorroidal surgery. * Concomitant anal fissure. * Concomitant perianal fistulae. * Concomitant rectal prolapse. * Inflamatory bowel disease. * Anal or colorrectal cancer.

Design outcomes

Primary

MeasureTime frameDescription
Hemorrhoidal Disease Symptom Scoreone yearA score that defines the frecuency of pain, pruritus, bleeding, soiling and prolapse. Score 0 to 20. Higher scores mean a worse outcome
Short Health Scale in Hemorrhoidal Diseaseone yeara subjective scale which defines symptom intensity, the patient's worrying and the role in impairment of daily activity. Score 4 to 28. Higher scores mean a worse outcome

Secondary

MeasureTime frameDescription
Postoperative Pain1 week after surgical procedurepain measured in visual analogic scale (VAS) Scale: 0 to 10. Higher scores mean a worse outcome
Fecal Incontinenceone year after surgical proceduremeasured in Wexner scale. Score 0 to 20. Higher scores mean a worse outcome

Countries

Spain

Baseline characteristics

Characteristic
Age, Continuous48 years
STANDARD_DEVIATION 2
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
7 / 2511 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026